Genetic or Genomic Counselling? The Opportunities and Challenges of Empowering Patients in the Era of Genome Sequencing

Yvonne Bombard, PhD
University of Toronto
Learning Outcomes:

  • Define ethical and counselling issues surrounding the generation of incidental genome sequencing results.

  • Describe patients' preferences and perceived utility of incidental genome sequencing results.

  • Explain Genomics ADvISER, a decision aid to engage patients in shared decision making concerning genome sequencing and receiving incidental results.

  • Dr. Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael's Hospital. She is an Assistant Professor at the University of Toronto in the Institute of Health Policy Management and Evaluation. Her research focuses on evaluating the adoption of new genomic technologies in clinical practice. She also conducts public and patient engagement research to advance health technology assessment and health service delivery. Dr. Bombard is active in numerous international policy advisory committees; her research informs policy development in this area. In 2014, Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a 'Rising Star' award from CIHR's Institute of Health Services and Policy Research in 2011. Recently, she has been awarded a CIHR Foundation grant as an Early Career Investigator, and she holds a CIHR New Investigator Award.

    Dr. Bombard holds a Fellowship from Yale University (Health Policy), a Fellowship from the Memorial Sloan-Kettering Cancer Center (Cancer Genomics) and a Fellowship from the University of Toronto (Health Services Research).